Search for: "Pfizer Inc." Results 101 - 120 of 1,516
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jun 2021, 12:32 pm by Tom Kosakowski
The latest installment of the CPR Institute's Young-ADR series features an interview with Timothy Shore, VP and Chief Ombudsman at Pfizer, Inc. [read post]
24 May 2021, 7:34 am by Deb Givens
The plaintiffs have accused Ranbaxy of delaying the launch of generic versions of Novartis AG’s high blood pressure drug Diovan, Pfizer Inc’s acid reflux drug Nexium and Genentech Inc’s antiviral drug Valcyte. [read post]
15 May 2021, 6:00 pm by Juvan Bonni
 Bashar Malkawi: Royalty Rate Determination in Patent Infringement Cases: The U.S. and China Compared (Source: SSRN) New Job Postings on Patently-O: Boston Scientific Clark+Elbing LLP Warner Norcross + Judd LLP – Patent Associate Attorney Warner Norcross + Judd LLP – Patent Agent Weaver Austin Villeneuve & Sampson LLP Murphy, Bilak & Homiller PLLC (MBH) McNeill Baur Faegre Drinker ALG Intellectual Property, LLC PTC Therapeutics Inc Miller & Martin Workman… [read post]
11 May 2021, 3:01 pm by Laura Ray
  As part of the original EUA request, Pfizer Inc. submitted a plan to continue monitoring the Vaccine’s safety, and this plan has been updated to include the newly authorized adolescent population. [read post]
26 Apr 2021, 7:42 am by Race to the Bottom
Novartis AG is working with Pfizer Inc. to fill vials quicker and to develop the mRNA needed for a new vaccine candidate produced by CureVA NV. [read post]
20 Apr 2021, 4:27 am by Rob Robinson
In the last year, the company’s data under management has grown by more than 40 percent as Druva supports industry leaders, disruptors, and pioneers including GameStop, Marriott, NASA, National Cancer Institute, Pfizer, Regeneron Pharmaceuticals, and Zoom. [read post]
18 Apr 2021, 5:21 pm by Juvan Bonni
Recent Headlines in the IP World: Kim Yun-Mi: BMS, Pfizer Win Final Suit for Eliquis Patent (Source: Korea Biomedical Review) David Hyman: Rakovina Therapeutics Inc. [read post]
16 Apr 2021, 12:48 pm by Jessica R. Corpuz
Medtronic, Inc., 496 U.S. 661, 671 (1990), Pfizer and BioNTech claim that they are permitted to “engage in otherwise infringing activities necessary to obtain regulatory approval,” including under their Emergency Use Application to the FDA. [read post]
15 Apr 2021, 1:42 pm by Tom Lamb
In August, the FDA declined to approve Gilead Inc’s experimental rheumatoid arthritis treatment filgotinib, which also belongs to the same class of oral drugs. [read post]
14 Mar 2021, 8:35 pm by Patent Docs
Stephen Bauer, retired, Medtronic Inc.; Dean Harts of 3M Enterprise Operations; and Sharon Reiche of Pfizer will provide an overview of significant IP policy concerns across different countries and regions based on IPO's comments made during the U.S. [read post]
28 Feb 2021, 5:51 pm by Sabrina I. Pacifici
The Pfizer and Moderna two-shot vaccines can only be kept at refrigerator temperatures for five or 30 days, respectively. [read post]
15 Feb 2021, 6:12 am by Kirk M. Hartung
In October, 2020, Allele Biotechnology and Pharmaceuticals sued Pfizer, Inc. [read post]
12 Feb 2021, 4:15 am by La'Cee Conley
Pfizer and BioNTech have hit back at Allele Biotechnology and Pharmaceuticals, Inc. [read post]
12 Feb 2021, 4:15 am by La'Cee Conley
Pfizer and BioNTech have hit back at Allele Biotechnology and Pharmaceuticals, Inc. [read post]
4 Feb 2021, 1:17 pm by Tom Kosakowski
Here are the nominees along links to any information published on the Ombuds Blog:Roy Baroff, CO-OP (incumbent) — Faculty & Staff Ombuds, North Carolina State University;Suzanne Diviney, CO-OP (incumbent) — Vice President, Office of the Ombuds Lead, Pfizer Inc. [read post]
9 Jan 2021, 9:16 am by Gregory B. Williams
January 7, 2021), the Court granted in part the motion of Defendants Hospira, Inc. and Pfizer, Inc. to stay Civil Action No. 20-0561 until 14 days after resolution of Amgen Inc. et al. v. [read post]